Strive Health Secures $166M in Series C Funding to Revolutionize Kidney Care

Strive Health is thrilled to announce a significant funding milestone, successfully raising $166 million in a recent financing round, which will accelerate its mission to revolutionize kidney care.

Strive Health is a pioneering provider of value-based kidney care solutions, specifically designed for innovative healthcare payors and providers.

Through a unique blend of high-touch care teams, cutting-edge technology, and seamless integration with local healthcare providers, Strive develops comprehensive kidney care systems that support patients throughout their entire healthcare journey, from chronic kidney disease (CKD) to end-stage renal disease (ESRD).

This substantial investment will enable Strive to enhance its offerings, scale its operations, and further refine its next-generation dialysis services.

With the backing of esteemed investors, including New Enterprise Associates, Town Hall Ventures, Echo Health Ventures, and Ascension Ventures, Strive is well-positioned to leverage differentiated capital, advanced technology, and deep healthcare expertise to drive transformative improvements in kidney care.

The funding will also facilitate strategic partnerships with commercial and Medicare Advantage payors, as well as health systems and physicians, allowing for flexible value-based payment arrangements that include total cost-of-care risk assumption.

By advancing its integrated kidney care systems and addressing the unique needs of its patient population, Strive Health is dedicated to improving health outcomes and enhancing the overall patient experience in the evolving landscape of kidney care.

This funding round marks a pivotal step forward in Strive's commitment to delivering high-quality, compassionate care to individuals battling kidney disease.